Home › Stroke › NCT04550728
Hybrid Robot+FES Stroke Rehabilitation
Assessment Followed by Home-based Hybrid Robot + FES Rehabilitation Post-stroke
Who can join
Ages 18 to 85 · All sexes
Full eligibility criteria
Inclusion Criteria: * Age 18-85; * Able to ambulate at least 10 meters without human assistance, with or without an assistive device * ≥ 6 months post stroke; * having a caregiver to assist in training at home. Exclusion Criteria: * having expressive and receptive aphasia; * an inability to follow multi-step commands; * enrolled in another lower limb rehabilitation program; * having severe pain in the paralyzed lower-limb; * \>30º ankle plantar flexion contracture; * Having implanted electronic device such as a pacemaker, spinal cord, or deep brain stimulator because FES may potentially interfere with their functions.
About the study
The investigators have developed a novel robot-guided stretching under intelligent control and combine it with active movement training, which helped increase joint ROM, reduce spasticity and joint stiffness, increase muscle force output, and improve locomotion. However, for stroke survivors with sensorimotor impairment, their peripheral muscle may not sufficiently be recruited. Functional electrical stimulation (FES), has been shown its advantage to activate the peripheral muscles for people with neurological conditions. The investigators thus make a hybrid robot-FES rehabilitation system, combining the advantage of robot and FES technologies for stroke motor recovery. The investigators further would like to translate the technologies from lab to home-based training. Thus, the investigators will conduct a randomized, controlled, primarily home-based clinical trial using an ankle robot alone or combined with functional electrical stimulation (FES) to treat sensorimotor and locomotion impairments post-stroke.
What is being tested
- Ankle robot training group (combination product)
- Ankle robot training and functional electrical stimulation(FES) group (combination product)
Sponsor: University of Maryland, Baltimore · Participants: 60 · Started: Aug 1, 2021
Contact the study team
- Li-qun Zhang, PhD · Phone: 410 706 2145
Official record on ClinicalTrials.gov — NCT04550728
Locations in the U.S.
| Maryland | University of Maryland School of Medicine, Baltimore |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.